BioOne Corporation
 

We are pleased to introduce INTERCEPT Blood System, an innovative and unique system to inactivate pathogens and lymphocytes in blood products, developed by Cerus Corporation

  

Whst'sNew
2007/11/10
BioOne runs a booth at The XVIIIth Regional Congress of ISBT/ Vietnam Hanoi, Asia
2007/10/5
BioOne sponsors a satellite seminar at the 14th Autumn Symposium of the Japan Society of Transfusion Medicine and Cell Therapy in Takamatsu
2007/6/2
BioOne sponsors a luncheon seminar at the 55th Annual Symposium of the Japan Society of Transfusion Medicine and Cell Therapy in Nagoya
2006/12/26
BioOne acquires exclusive manufacture and Commercialization right for INTERCEPT plasma in East Asia
2006/7/20
BioOne announces 650 Million Yen Financing
2005/12/12
Move to new office MAP

Copyright (C) 2008 All rights reserved BioOne Corporation

BioOne Corporation News&Event Mission Company Profile Products Profile Contact Us Privacy Policy Home Japanese